News Archive
Here you will find archived C-Path news events. Please feel free to browse the documents and news releases below to learn more about what have been doing here at the Critical Path Institute.
2007 News...
Thanks to C-Path's role as an independent, neutral third party, it has been successful in bringing together scientists from the FDA, the industry it regulates and academia.
October 2007 - C-Path Awarded Grant to Continue Drug Safety Work...
The Critical Path Institute (C-Path) announced the receipt of a $4 million grant from the Agency for Healthcare Research and Quality (AHRQ) to continue support for its Arizona Center for Education and Research on Therapeutics (AzCERT).
October 2007 - C-Path and Ventana Medical Systems to collaborate...
The Critical Path Institute (C-Path) and Ventana Medical Systems, Inc. (Ventana) (NASDAQ: VMSI) today released additional information about C-Path's $2.1 million grant from Science Foundation Arizona (SFAz) to fund a collaboration project with the U.S. Food and Drug Administration (FDA) and the National Cancer Institute (NCI) to develop a standard testing and evaluation process for companion diagnostics and their associated targeted cancer therapies.
Science Foundation Arizona (SFAz), through its Strategic Research Group (SRG) program, today announced that it is granting nearly $10 million to eight outstanding research collaborations throughout the state.
To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administration (FDA) in 2004 published a report titled Challenge and Opportunity on the Critical Path to New Medical Products.
May 2007 - C-Path makes progress to safely speed medical discoveries to market...
William Mattes of C-Path spoke at the Arizona Pavillion May 8th 2007 about the Predictive Safety Testing Consortium.
April 2007 - Pharmaceutical companies and FDA making strides...
Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Food and Drug Administration approval to bring the drugs to market.
March 2007 - Raymond Woosley, M.D., Ph.D., provides expert testimony in congressional hearings...
President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterday at the Committee on Energy and Commerce's Subcommittee Hearing on Oversight and Investigations entitled "The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply."
March 2007 - C-Path adopts Rosetta Resolver® System for the PSTC...
Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-Path's Predictive Safety Testing Consortium.
2006 News...
The Critical Path Institute (C-Path) today announced seven new members that have recently joined the Predictive Safety Testing Consortium (PSTC)...
November 2006 - Tucson nonprofit seeks to get cures to patients faster...
A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and development had been rising for the previous decade, applications for new drugs and medical products had been falling.
September 2006 - C-Path receives $675,000.00 award for FDA collaboration...
The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of what is anticipated to be a multi-year, multi phased research program in cardiovascular disease.
April 2006 - C-Path announces the appointment of Jeffery Cossman, M.D., as Chief Scientific Officer...The Critical Path Institute (C-Path), today announced the appointment of Jeffrey Cossman, M.D., an internationally recognized expert in molecular pathology, to the position of Chief Scientific Officer.
April 2006 - Valley Fever cure a step closer...
The federal government is backing the first potential cure for valley fever, a serious lung disease that has spiked in recent years and afflicted thousands of Arizonans.
March 2006 - C-Path forms drug testing pact...
The Tucson-based Critical Path Institute on Thursday announced an unprecedented agreement with eight major pharmaceutical companies to share drug-testing methods in an effort to improve drug safety.
March 2006 - FDA release: The Predictive Safety Testing Consortium...
The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Safety Testing Consortium between C-Path and five of America’s largest pharmaceutical companies to share internally developed laboratory methods to predict the safety of new treatments before they are tested in humans.
February 2006 - Drug research institute adds liason from UA...
The retired head of research at the University of Arizona has joined the Tucson-based Critical Path Institute, a UA- and FDA-affiliated drug research institute, as head of its affiliations with research universities.
January 2006 - C-Path to spur medical innovation...
We all remember the Vioxx scare and authorities say it could happen again. However, the FDA is stepping up its efforts to improve the safety of prescription drugs and here in Tucson a research group is piloting a program to examine and detect them carefully.